Suppr超能文献

针对 ICU 中产生超广谱β-内酰胺酶肠杆菌科的传播的普遍或靶向方法:成本效益分析。

Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.

机构信息

IAME, UMR 1137, INSERM, Paris, France.

University of Paris Diderot, Sorbonne Paris Cité, Paris, France.

出版信息

BMJ Open. 2017 Nov 3;7(11):e017402. doi: 10.1136/bmjopen-2017-017402.

Abstract

OBJECTIVE

Several control strategies have been used to limit the transmission of multidrug-resistant organisms in hospitals. However, their implementation is expensive and effectiveness of interventions for the control of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) spread is controversial. Here, we aim to assess the cost-effectiveness of hospital-based strategies to prevent ESBL-PE transmission and infections.

DESIGN

Cost-effectiveness analysis based on dynamic, stochastic transmission model over a 1-year time horizon.

PATIENTS AND SETTING

Patients hospitalised in a hypothetical 10-bed intensive care unit (ICU in a high-income country.

INTERVENTIONS

Base case scenario compared with (1) universal strategies (eg, improvement of hand hygiene (HH) among healthcare workers, antibiotic stewardship), (2) targeted strategies (eg, screening of patient for ESBL-PE at ICU admission and contact precautions or cohorting of carriers) and (3) mixed strategies (eg, targeted approaches combined with antibiotic stewardship).

MAIN OUTCOMES AND MEASURES

Cases of ESBL-PE transmission, infections, cost of intervention, cost of infections, incremental cost per infection avoided.

RESULTS

In the base case scenario, 15 transmissions and five infections due to ESBL-PE occurred per 100 ICU admissions, representing a mean cost of €94 792. All control strategies improved health outcomes and reduced costs associated with ESBL-PE infections. The overall costs (cost of intervention and infections) were the lowest for HH compliance improvement from 55%/60% before/after contact with a patient to 80%/80%.

CONCLUSIONS

Improved compliance with HH was the most cost-saving strategy to prevent the transmission of ESBL-PE. Antibiotic stewardship was not cost-effective. However, adding antibiotic restriction strategy to HH or screening and cohorting strategies slightly improved their effectiveness and may be worthy of consideration by decision-makers.

摘要

目的

为了限制医院中多重耐药菌的传播,已经采用了多种控制策略。然而,这些策略的实施成本高昂,并且对于控制产超广谱β-内酰胺酶肠杆菌科(ESBL-PE)传播的干预措施的有效性存在争议。在这里,我们旨在评估预防 ESBL-PE 传播和感染的基于医院的策略的成本效益。

设计

基于动态、随机传播模型的 1 年时间框架内的成本效益分析。

患者和设置

假设在一个高收入国家的 10 张病床的重症监护病房(ICU)住院的患者。

干预措施

基础案例情景与(1)普遍策略(例如,提高医护人员的手卫生(HH),抗生素管理),(2)靶向策略(例如,在 ICU 入院时对患者进行 ESBL-PE 筛查和接触预防或对携带者进行群体隔离)和(3)混合策略(例如,靶向方法与抗生素管理相结合)进行比较。

主要结果和测量

ESBL-PE 传播、感染、干预成本、感染成本、每例感染避免的增量成本。

结果

在基础案例情景中,每 100 例 ICU 入院发生 15 例 ESBL-PE 传播和 5 例感染,代表平均成本为 94792 欧元。所有控制策略都改善了健康结果,并降低了与 ESBL-PE 感染相关的成本。总体成本(干预和感染成本)最低的是接触患者前后从 55%/60%提高到 80%/80%的 HH 合规性提高。

结论

提高 HH 的合规性是预防 ESBL-PE 传播的最具成本效益的策略。抗生素管理并不具有成本效益。然而,将抗生素限制策略添加到 HH 或筛查和群体隔离策略中,略微提高了它们的效果,可能值得决策者考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f75/5722099/e5efa4a4ee2f/bmjopen-2017-017402f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验